Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
TriPRIL CAR T Cell Therapy for Multiple Myeloma
Recruiting1 awardPhase 1
Boston, Massachusetts
This trial is testing TriPRIL CAR T Cells, a new treatment that uses a patient's own immune cells to fight multiple myeloma that has come back or not responded to other treatments. The treatment involves modifying the patient's T cells to better attack cancer cells. About 18 people will participate, receiving one infusion and being monitored for an extended period. This type of therapy has shown promising results in treating various cancers, including multiple myeloma.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service